Announcements Trials

Browse Landscape

Phase

Phase 1 6 Phase 1/2 2 Phase 2/3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 2 Sarcoma 1 Genitourinary 1 Gastrointestinal 1

Conditions

Prostatic Neoplasms 1427 Carcinoma, Renal Cell 587 Urinary Bladder Neoplasms 368 Kidney Neoplasms 257 Carcinoma, Transitional Cell 190 Neoplasm Metastasis 163 Neoplasms 124 Melanoma 83 Breast Neoplasms 80 Carcinoma, Non-Small-Cell Lung 78 Testicular Neoplasms 67 Ovarian Neoplasms 62 Sarcoma 55 Urethral Neoplasms 51 Non-Muscle Invasive Bladder Neoplasms 51 Wilms Tumor 49 Lung Neoplasms 45 Colorectal Neoplasms 44 Uterine Cervical Neoplasms 39 Neuroblastoma 39 Penile Neoplasms 37 Pancreatic Neoplasms 37 Urologic Neoplasms 34 Recurrence 32 Lymphoma, Non-Hodgkin 32 Ureteral Neoplasms 28 Osteosarcoma 28 Testicular Germ Cell Tumor 26 Small Cell Lung Carcinoma 26 Head and Neck Neoplasms 26

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Adenoviridae Infections × Genitourinary × Clear all

NCT02143804 2026-04-02

exBOND

CG Oncology, Inc.

Phase 2 Withdrawn

Adenoviridae Infections, Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡